3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Colorectal Neoplasms
43
Neoplasms
19
Neoplasm Metastasis
17
Rectal Neoplasms
12
Colonic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
5
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma
3
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Advanced Solid Tumors
2
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Solid Tumor, Adult
1
Kidney Neoplasms
1
Histiocytosis
1
Gastrointestinal Neoplasms
1
Exanthema
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Brain Neoplasms
1
Interventions
pembrolizumab
6
Proton Therapy
3
spartalizumab
2
Rosuvastatin Calcium
2
Paclitaxel
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
toripalimab
1
sotorasib
1
peposertib
1
osimertinib
1
necitumumab
1
mirdametinib
1
leronlimab
1
apatinib
1
amivantamab
1
abemaciclib
1
Valganciclovir
1
Trastuzumab
1
Therapeutics
1
Rifampin
1
Radiotherapy
1
PankoMab-GEX
1
Panitumumab
1
Midazolam
1
Metformin
1
MEK inhibitor I
1
Jupiter
1
JPT1 protein, human
1
Itraconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Solid Tumor, Adult
×
Panitumumab
×
Clear all
NCT03360734
2021-07-12
GATTO
Glycotope GmbH
Phase 1
Completed
50 enrolled